[The selective waiving of neoadjuvant (chemo)radiotherapy for rectal cancer lacks evidence].

about

[The selective waiving of neoadjuvant (chemo)radiotherapy for rectal cancer lacks evidence].

Item

http://www.wikidata.org/entity/Q54686142

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

[The selective waiving of neoa ...... rectal cancer lacks evidence].

@en

[The selective waiving of neoadjuvant

@nl

type

Item

label

[The selective waiving of neoa ...... rectal cancer lacks evidence].

@en

[The selective waiving of neoadjuvant

@nl

prefLabel

[The selective waiving of neoa ...... rectal cancer lacks evidence].

@en

[The selective waiving of neoadjuvant

@nl

P1476

[The selective waiving of neoa ...... rectal cancer lacks evidence].

@en

P2093

D Habermehl

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.

Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04.

Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy.

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.

Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer.

MRI-based treatment of rectal cancer: is prognostication of the recurrence risk solid enough to render radiation redundant?

Rectal Cancer, Version 2.2015.

Individualized radiotherapy by combining high-end irradiation and magnetic resonance imaging.

The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy.

Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.

P2888

s00104-016-0279-x

P304

884-886

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00104-016-0279-X

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27573148

http://www.w3.org/2001/XMLSchema#string